To further validate the efficacy of WBC100 on c‐Myc overexpressing tumor in vivo, we established human gastric cancer mouse models using MGC‐803 cell line with high c‐Myc protein level (Figure S8A, Supporting Information) and determined WBC100 activity under the same condition. The gene discussed is MYC; the disease is neoplasm.